Showing 8,741 - 8,760 results of 34,683 for search '(( 50 ((nn decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( 5 point decrease ))', query time: 1.06s Refine Results
  1. 8741

    Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  2. 8742

    Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  3. 8743

    Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  4. 8744

    Data Sheet 2_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  5. 8745
  6. 8746
  7. 8747
  8. 8748

    Schematic representation showing different phases and outcomes of stochastic bubbles for (4) with <i>b</i> = 0.42, <i>g</i> = −0.04, <i>σ</i><sub><i>x</i></sub> = 0.6, <i>σ</i><sub... by Damian Smug (5040890)

    Published 2018
    “…<b>(A)</b> and <b>(B)</b> Foreshocks {1/2} and {3/4} preceding the main crash {5/6} are clearly visible. The time intervals between the consecutive local peaks and corrections decrease as a result of at least two factors: first, until around <i>z</i> = 0.2, the price <i>x</i> accelerates making it prone to take a time consuming detour for smaller <i>x</i> {2} that becomes less impactful compared to when <i>x</i> is larger {4}. …”
  9. 8749
  10. 8750
  11. 8751
  12. 8752
  13. 8753

    CD4<sup>+</sup>CD25<sup>hi</sup>FOXP3<sup>+</sup> Regulatory T Cells and Cytokine Responses in Human Schistosomiasis before and after Treatment with Praziquantel by Yvonne Schmiedel (785554)

    Published 2015
    “…Cytokines responses (IFN-γ, IL-5, IL-10, IL-13, IL-17 and TNF) were integrated using Principal Component Analysis (PCA). …”
  14. 8754
  15. 8755
  16. 8756

    Experiment 2D and 5D: Progressive Sample Scaling Algorithm To Solve Many-Affine BBOB Functions. by Boris Almonacid (4110337)

    Published 2024
    “…Optionally, there is a factor value that can increase or decrease the number of points during execution in the Scaling stage.…”
  17. 8757
  18. 8758
  19. 8759
  20. 8760